Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Professor Gero Miesenböck, the Waynflete Professor of Physiology and Director of the Centre for Neural Circuits and Behaviour, is one of four scientists to receive the 2019 Warren Alpert Foundation Prize for his pioneering work in the field of optogenetics. Optogenetics uses light and genetic modification to control the activity of cells in the brain, allowing researchers to precision-target neurons in the brain and study how the activity of these cells contributes to simple and complex behaviors. Professor Miesenböck played a crucial role in the field, being the first to demonstrate optogenetic control of neural activity and animal behaviour. His subsequent discoveries on the neural basis of reward, the regulation and function of sleep, and the control of sexually dimorphic behaviour proved the utility of optogenetics for neurobiological research.

On receiving the award, Professor Gero Miesenböck said: “I am delighted to be in such good company, and I’m not talking just about my co-laureates. Many of my scientific heroes are among the previous recipients of the Warren Alpert Prize.”

Professor Gero Miesenböck was honoured alongside Edward Boyden, the Y. Eva Tan Professor in Neurotechnology at MIT, Karl Deisseroth, the D.H. Chen Professor of Bioengineering and of Psychiatry and Behavioural Sciences at Stanford University and Peter Hegemann, the Hertie professor of Neuroscience at Humboldt University of Berlin.

The Warren Alpert Foundation, in association with Harvard Medical School, honours scientists whose work has improved the understanding, prevention, treatment or cure of human disease.

The honourees will share a $500,000 prize and will be recognised at a daylong symposium on 3 October at Harvard Medical School.

Read more (CNCB wesbite)

Read more (Warren Alpert Foundation Prize website)

Similar stories

Mootaz Salman set to target new treatments for stroke

The Chief Scientist Office of the Government of Scotland has awarded a collaborative grant of £298,966 to Dr Mootaz Salman to seek new therapeutic avenues to treat stroke.

Gero Miesenböck awarded 2023 Japan Prize

Congratulations are in order for Professor Gero Miesenböck, who has been awarded the 2023 Japan Prize in the field of Life Sciences, together with Professor Karl Deisseroth, for pioneering work in the field of optogenetics.

Mootaz Salman receives prestigious science award from Iraq

Congratulations are in order for Dr Mootaz Salman, who has received the National Medal of Distinctive Scientific Achievement by the Government of Iraq.

Professor Denis Noble awarded the Lomonosov Gold Medal

The Russian Academy of Sciences has awarded its highest accolade, the Lomonosov Gold Medal, to Emeritus Professor Denis Noble CBE, FRS.

Professor Dame Frances Ashcroft awarded the Manpei Suzuki International Prize for Diabetes Research

The 2022 Manpei Suzuki International Prize for Diabetes Research recognises original and excellent achievements in diabetes research. Professor Ashcroft is the first women to win in the 15 years this prestigious Prize has been awarded.